feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs",https://www.benzinga.com/general/biotech/20/10/17752246/the-daily-biotech-pulse-mesoblast-slumps-on-fda-rejection-astrazenecas-breakthrough-therapy-desig,https://j.mp/3jo3xFL
